Event Details

Safeguard Scientifics to Present at the 2017 Corrona Advisory Roundtable

December 8, 2017 08:15 AM EST
New York, NY


  • Gary J. Kurtzman, MD, Managing Director, Safeguard Scientifics

With the proliferation and approval of additional biologic and targeted therapies in autoimmune diseases, clinicians, payers, and patients are faced with a dizzying array of therapeutic options. For rational decision-making, it is apparent that head-to-head studies of biologic therapies are ideal and the ‘gold standard’ for evidence-based decision-making.

Safeguard's Managing Director, Gary J. Kurtzman, MD, will present at 3:20pm ET during session #3 entitled, "Review of data sources and gaps, and evidence for comparative and cost effectiveness going forward." Specifically, Dr. Kurtzman will focus on Artificial Intelligence and the Role of Machine Learning to Derive new Insights from Different Clinical Sources.

Click here for additional information.


The New York Athletic Club, 180 Central Park South, New York, NY 10019